Comparison between Curis Lifesciences IPO and Tankup Engineers IPO.
Curis Lifesciences IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Tankup Engineers IPO is a SME Bookbuilding proposed to list at NSE SME.
| Curis Lifesciences IPO | Tankup Engineers IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Finaax Capital Advisors Private Limited | Hem Securities Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | RS Wealth Management Private Limited | Hem Finlease Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Curis Lifesciences IPO is up to ₹26.14 Cr whereas the issue size of the Tankup Engineers IPO is up to ₹18.55 Cr. The final issue price of Curis Lifesciences IPO is ₹128.00 per share and of Tankup Engineers IPO is ₹140.00 per share.
| Curis Lifesciences IPO | Tankup Engineers IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹120.00 per share | ₹133.00 per share |
| Issue Price (Upper) | ₹128.00 per share | ₹140.00 per share |
| Issue Price (Final) | ₹128.00 per share | ₹140.00 per share |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 1000 shares | 1000 shares |
| Fresh Issue Size | 20,42,000 shares | 13,25,000 shares |
| Fresh Issue Size (Amount) | up to ₹26.14 Cr | up to ₹18.55 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 20,42,000 shares | 13,25,000 shares |
| Issue Size Total (Amount) | up to ₹26.14 Cr | up to ₹18.55 Cr |
Curis Lifesciences IPO opens on Nov 07, 2025, while Tankup Engineers IPO opens on Apr 23, 2025. The closing date of Curis Lifesciences IPO and Tankup Engineers IPO is Nov 11, 2025, and Apr 25, 2025, respectively.
| Curis Lifesciences IPO | Tankup Engineers IPO | |
|---|---|---|
| Anchor Bid Date | Nov 06, 2025 | Apr 22, 2025 |
| Issue Open | Nov 07, 2025 | Apr 23, 2025 |
| Issue Close | Nov 11, 2025 | Apr 25, 2025 |
| Basis Of Allotment (Tentative) | Nov 12, 2025 | Apr 28, 2025 |
| Initiation of Refunds (Tentative) | Nov 13, 2025 | Apr 29, 2025 |
| Credit of Share (Tentative) | Nov 13, 2025 | Apr 29, 2025 |
| Listing date (Tentative) | Nov 14, 2025 | Apr 30, 2025 |
| Anchor Lockin End date 1 | Dec 11, 2025 | May 28, 2025 |
| Anchor Lockin End date 2 | Feb 09, 2026 | Jul 27, 2025 |
Curis Lifesciences IPO P/E ratio is 12.44, as compared to Tankup Engineers IPO P/E ratio of 21.26.
| Curis Lifesciences IPO | Tankup Engineers IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Curis Lifesciences Ltd.'s revenue increased by 38% and profit after tax (PAT) rose by 25% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 92.68 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 68.03 | 73.65 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.44 | 21.26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹103.48 Cr. | ₹74.13 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 55.25 | 107.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 27.83 | 46.49 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.96 | 1.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹10.29 | ₹6.59 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 37.62 | 69.75 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Curis Lifesciences IPO Retail Individual Investors (RII) are offered 7,16,000 shares while in Tankup Engineers IPO retail investors are offered 7,16,000 shares. Qualified Institutional Buyers (QIB) are offered 4,08,000 shares in Curis Lifesciences IPO and 2,58,000 shares in Tankup Engineers IPO.
| Curis Lifesciences IPO | Tankup Engineers IPO | |
|---|---|---|
| Anchor Investor Reservation | 6,09,000 shares | 3,85,000 shares |
| Market Maker Reservation | 1,08,000 shares | 70,000 shares |
| QIB | 4,08,000 shares | 2,58,000 shares |
| NII | 3,09,000 shares | 1,94,000 shares |
| RII | 7,16,000 shares | 4,52,000 shares |
| Employee | 0 shares | 36,000 shares |
| Others | ||
| Total | 20,42,000 shares | 13,25,000 shares |
Curis Lifesciences IPO subscribed 74.39x in total, whereas Tankup Engineers IPO subscribed 124.67x.
| Curis Lifesciences IPO | Tankup Engineers IPO | |
|---|---|---|
| QIB (times) | 96.17x | 43.65x |
| NII (times) | 115.46x | 437.62x |
| Big NII (times) | 142.74x | |
| Small NII (times) | 60.38x | |
| RII (times) | 44.28x | 46.51x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 74.39x | 124.67x |
